ATI-502

unknown · Aclaris Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ATI-502, covering 2020-09-17 to 2020-09-17. Get the full timeline:

Most recent: Clinical Trial Update: ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT) [Phase 2]

See pricing